Pilot trial finds tocilizumab may improve inflammatory depression
A small clinical trial has provided early evidence that an existing anti-inflammatory drug may offer a new treatment path for patients with difficult-to-treat depression.
A small clinical trial has provided early evidence that an existing anti-inflammatory drug may offer a new treatment path for patients with difficult-to-treat depression.